Log In
BCIQ
Print this Print this
 

HL178

  Manage Alerts
Collapse Summary General Information
Company HanAll Biopharma Co. Ltd.
DescriptionNegative regulator of thioredoxin-interacting protein (TXNIP)
Molecular Target Thioredoxin interacting protein (TXNIP)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Endocrine (unspecified)
Indication DetailsTreat Wolfram syndrome
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today